MedPath

Sildenafil citrate effect on in vivo human trophoblast research

Not Applicable
Completed
Conditions
Placental vascular flow
Pregnancy and Childbirth
Registration Number
ISRCTN36718005
Lead Sponsor
Servicio Ginecologia y Obstetricia Hospital General de Valencia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
60
Inclusion Criteria

1. Healthy women between 20-40 years old
2. Confirmed pregnant viability without any obstetric complication
3. First trimester gestational age
4. Coming to hospital for legal medical abortion

Exclusion Criteria

1. Obstetric risk factors: recurrent miscarriage, previous preeclamsia and hematology disease
2. Current use of vasoactive drugs (mainly related to hypertension treatment)
3. Toxic substances abuse
4. Threatened abortion symptoms
5. Sildenafil citrate contraindications, as are described in the prescribing information formulary (excluding pregnancy)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath